Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

I see a lot of complaining why pain ANDAs never got materialized, thanks for thoughtful answer. As you said switching to CNS was a good decision and with the same prorated market share we will double the revenue compare to pain drugs.

I read that post very carefully, and I did not see any answers about why the opioids were never commercialized. Still waiting for that answer, meshcan. Likewise, adding the CNS stimulants instead of switching to them is the most obvious business decision, especially for a company with little income, no access to capital, minimal legal risk, and "going concern" caveats from their auditor.

These are simple, straightforward questions that anyone is welcome to answer. Yes, dear investor, we know you are glad that Nasrat wasted millions of dollars and tens of millions of ELTP shares developing these drugs and then sold them off to his buddies for pennies on the dollar. We know you are happy to have $30M revenue instead of $100M revenue, but why? Make it make sense for us, from a rational business perspective. We're waiting.